Back to search

Article

Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocol

2024-10-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> There is an absence of real-world evidence, especially from low- and middle-income countries (LMICs), on the implementation successes and challenges of COVID-19 test and treat (T&T) programs. In 2022, nirmatrelvir/ritonavir was provided as standard of care for mild to moderate COVID-19 treatment in eight LMICs (Ghana, Kenya, Laos, Malawi, Nigeria, Rwanda, Uganda and Zambia)....

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2ac4c838-6484-5a97-ab5f-d1aab087a5da
DOI
10.1101/2024.10.25.24316111
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mixed methods implementation research of oral antiviral treatment for COVID-19 in low and middle-income countries: a study protocolDOI 10.1101/2024.10.25.24316111
Select a neighboring publication to make it the new centre.